Darren Head has been named chief executive officer of Cytovance, a bio-CMO specializing in the production of therapeutic proteins and antibodies from mammalian cell culture.

Mr. Head was previously at Immucor, where he served as vice president of worldwide operations, overseeing the manufacturing of biological products in the U.S., Europe and Canada. Prior to that, he was an operations manager and project manager for such companies as Aronex Pharmaceuticals, Allergan Optical and Abbott Laboratories.

“Darren is a very accomplished executive ready to immediately take the helm with 18 years of broad experience in both the scientific and business sides of our industry,” said William Canfield M.D. Ph.D., chairman of Cytovance Biologics. “It is critical for the advancement of Cytovance that the CEO has the vision, practical industry knowledge and experience to ignite and sustain new growth in this business segment. We are confident Darren Head is that executive.”